Avadel Pharmaceuticals (AVDL) Operating Leases (2019 - 2022)
Historic Operating Leases for Avadel Pharmaceuticals (AVDL) over the last 4 years, with Q3 2022 value amounting to $1.0 million.
- Avadel Pharmaceuticals' Operating Leases fell 2972.6% to $1.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.0 million, marking a year-over-year decrease of 2972.6%. This contributed to the annual value of $1.7 million for FY2021, which is 722.83% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Operating Leases stood at $1.0 million for Q3 2022, which was down 2972.6% from $1.3 million recorded in Q2 2022.
- Avadel Pharmaceuticals' 5-year Operating Leases high stood at $4.9 million for Q1 2019, and its period low was $1.0 million during Q3 2022.
- In the last 4 years, Avadel Pharmaceuticals' Operating Leases had a median value of $1.8 million in 2020 and averaged $2.3 million.
- Per our database at Business Quant, Avadel Pharmaceuticals' Operating Leases crashed by 5589.42% in 2020 and then tumbled by 722.83% in 2021.
- Quarter analysis of 4 years shows Avadel Pharmaceuticals' Operating Leases stood at $2.3 million in 2019, then decreased by 20.66% to $1.8 million in 2020, then fell by 7.23% to $1.7 million in 2021, then tumbled by 39.89% to $1.0 million in 2022.
- Its last three reported values are $1.0 million in Q3 2022, $1.3 million for Q2 2022, and $1.5 million during Q1 2022.